Stefana Oana Popescu

Dr. Stefana Oana Popescu


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
EBEdmond Barcan
Edmond Barcan
CDCarmen Duta
Carmen Duta
GSGeorgiana-Adeline Staicu
Georgiana-Adeline Staicu
SAStefan-Alexandru Artene
Stefan-Alexandru Artene
OAOana Alexandru
Oana Alexandru
ADAnica Dricu
Anica Dricu
Glioblastoma (GBM) is an aggressive brain tumor characterized by molecular complexity and resistance to conventional treatments, including surgery, radiation, and chemotherapy. Despite these challenges, advancements in receptor tyrosine kinase (RTK) research, combined with multi-omics approaches, hold promise for improving patient outcomes and survivability. RTKs are central to GBM progression, influencing cell proliferation, survival, and angiogenesis. However, the complexity of RTK signaling necessitates a broader, integrative perspective, which has been enabled by the emergence of -omics sciences. Multi-omics technologies—including genomics, transcriptomics, proteomics, and metabolomics—offer unprecedented insights into the molecular landscape of GBM and its RTK-driven pathways. Genomic studies have revealed mutations and amplifications in RTK-related genes, while transcriptomics has uncovered alterations in gene expression patterns, providing a clearer picture of how these aberrations drive tumor behavior. Proteomics has further delineated changes in protein expression and post-translational modifications linked to RTK signaling, highlighting novel therapeutic targets. Metabolomics complements these findings by identifying RTK-associated metabolic reprogramming, such as shifts in glycolysis and lipid metabolism, which sustain tumor growth and therapy resistance. The integration of these multi-omics layers enables a comprehensive understanding of RTK biology in GBM. For example, studies have linked metabolic alterations with RTK activity, offering new biomarkers for tumor classification and therapeutic targeting. Additionally, single-cell transcriptomics has unveiled intratumoral heterogeneity, a critical factor in therapy resistance. This article highlights the transformative potential of multi-omics in unraveling the complexity of RTK signaling in GBM. By combining these approaches, researchers are paving the way for precision medicine strategies that may significantly enhance diagnostic accuracy and treatment efficacy, providing new hope for patients facing this devastating disease.

1 March 2025 in GERMS
Verified
Journal Article
Open access
GDGheorghe Gindrovel Dumitra
Gheorghe Gindrovel Dumitra
CDCarmen-Adriana Dogaru
Carmen-Adriana Dogaru
SASandra Adalgiza Alexiu
Sandra Adalgiza Alexiu
DSDorica Sănduțu
Dorica Sănduțu
CBCosmina Berbecel
Cosmina Berbecel
ATAdina Turcu-Stiolica
Adina Turcu-Stiolica
Human papilloma virus (HPV) vaccination is a key strategy for preventing HPV-related cancers, yet vaccine hesitancy remains a challenge due to persistent myths and misconceptions. This study aimed to identify the most frequently encountered HPV vaccine-related myths in clinical practice from the perspective of family doctors and to assess differences in their prevalence between urban and rural populations. A cross-sectional study was conducted among family doctors in Romania who reported common myths encountered when discussing HPV vaccination with parents and women eligible for catch-up vaccination. The analysis focused on identifying the most prevalent perceived myths and assessing differences between urban and rural settings, age groups and genders, using Kruskal-Wallis test, followed by post-hoc Dunn’s tests with Holm correction to account for multiple comparisons, as well as Chi-square tests. The most frequently reported myths overall were “The HPV vaccine is only for girls” (mean score±SD, 2.91±1.27), “The HPV vaccine has severe and long-term side effects” (mean score±SD, 2.83±1.27), and “There are too many new vaccines” (mean score±SD, 2.77±1.3). Rural respondents reported significantly higher belief in concerns related to vaccine safety, effectiveness, increasing number of vaccines, necessity in monogamous individuals, fear of injections, and concerns about promiscuity, particularly in their perception of parents of adolescent girls. Family doctors consider that persistent myths continue to fuel vaccine hesitancy, especially in rural areas. Strengthening family doctors' communication skills through motivational interviewing and evidence-based counseling is essential. Public health efforts should focus on targeted educational interventions and social prescription tools to improve vaccine acceptance and reduce the burden of HPV-related diseases.

14 March 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
SPStefana Oana Popescu
Stefana Oana Popescu
AMAndreea Mihai
Andreea Mihai
Adina Turcu-StiolicaAdina Turcu-Stiolica
Adina Turcu-Stiolica
ELElena Carmen Lupu
Elena Carmen Lupu
DCDiana Maria Cismaru
Diana Maria Cismaru
Mititelu MagdalenaMititelu Magdalena
Mititelu Magdalena
Background/Objectives: This study examines the relationship between visceral fat (VF), metabolic health, and dietary patterns in patients with obstructive bronchial diseases (OBDs) using bioelectrical impedance analysis (BIA). Methods: A total of 75 patients diagnosed with OBD, including chronic obstructive pulmonary disease (COPD) and/or asthma, were assessed for VF levels via BIA. Dietary habits were evaluated using a structured questionnaire to explore their correlation with VF accumulation. Results: The study cohort comprised predominantly male participants (66.7%), with the majority aged between 61 and 70 years (46.7%). Significant gender differences in VF distribution were observed, with 60% of females maintaining normal VF levels (1–9) compared to only 28% of males, while 38% of males exhibited very high VF levels (15–30; p = 0.003). Body mass index (BMI) showed a strong correlation with VF (p < 0.0001), as overweight and obese individuals predominantly displayed elevated VF levels (≥10). Moreover, metabolic syndrome (MS) was present in 66.7% of participants, with these individuals exhibiting significantly higher VF levels compared to those without MS (p = 0.001). Dietary analysis revealed that frequent consumption of fast food (r = 0.717, p < 0.001), carbonated drinks (r = 0.366, p = 0.001), and refined carbohydrates (r = 0.438, p < 0.001) was significantly associated with increased VF accumulation. Conversely, higher intake of water (r = −0.551, p < 0.001), fruits (r = −0.581, p < 0.001), and vegetables (r = −0.482, p < 0.001) correlated with lower VF levels. Lack of physical activity was also strongly linked to VF accumulation (r = 0.481, p < 0.001), further reinforcing the role of lifestyle factors in metabolic health. Conclusions: The findings underscore the significant impact of dietary habits and physical activity on VF accumulation in OBD patients. BMI and MS emerged as critical predictors of VF, while unhealthy dietary patterns and sedentary lifestyles further exacerbated VF deposition. Elevated VF levels were linked to adverse lipid profiles, reinforcing the need for dietary and lifestyle modifications in managing metabolic health among OBD patients. Although no direct association was identified between VF and forced expiratory volume in one second (FEV1), the results highlight the necessity of integrated nutritional and metabolic interventions in the management of chronic respiratory diseases.

Verified
Journal Article
Open access
PDF file
SPStefana Oana Popescu
Stefana Oana Popescu
DPDelia Codruta Popa
Delia Codruta Popa
OAOana Alexandru
Oana Alexandru
ADAnica Dricu
Anica Dricu
Brain tumor (BT) patients can experience neurological complications as a result of the disease itself or after exposure to anticancer treatment. It is already known that BT patients have a poor survival and quality of life due to tumor progression, but also to various complications. The neurological complications may represent obstacles in patient management and require multidisciplinary collaboration. Although new methods of surgery, radiation therapy and pharmacotherapy have been designed in the last few years in order to prevent, mitigate, or manage the adverse effects of classical therapies, the overall survival of patients with BTs, especially glioblastoma (GB), remain poor. In this review we provide an overview of the most commo022328n neurological complications of BTs, as well as tumor therapies. We present what is already known on the topic but also the newest clinical data, and the results of clinical trials from the last few years. We also make a summary of the strategies capable of managing or even preventing these adverse effects.

13 March 2026 in Applied Sciences
Verified
Journal Article
Open access
PDF file
E(Elena-Victoria Manea (Carneluti)
Elena-Victoria Manea (Carneluti)
Virginia Maria RadulescuVirginia Maria Radulescu
Virginia Maria Radulescu
Cristina Floriana PanaCristina Floriana Pana
Cristina Floriana Pana
IGIlona Andreea Georgescu
Ilona Andreea Georgescu
MȘMircea-Sebastian Șerbănescu
Mircea-Sebastian Șerbănescu
SAStefan-Alexandru Artene
Stefan-Alexandru Artene
Early risk stratification of COVID-19 severity in oncology patients is critical for improving clinical outcomes and optimizing hospital resource allocation. This study proposes a rule-based clinical decision support system (CDSS) designed for integration into digital triage workflows. In practical terms, the score is intended to be applied at hospital admission or triage, where demographic and comorbidity information is routinely available. The computed score can automatically flag high-risk oncology patients for intensified monitoring or early ICU evaluation, supporting rapid resource allocation while preserving clinician decision-making. Using retrospective clinical data from hospitalized oncological patients with confirmed SARS-CoV-2 infection, we developed a scoring algorithm based on four common comorbidities: age ≥ 70, obesity, diabetes mellitus, and hypertension. Each factor was assigned a weighted contribution to a cumulative score ranging from 0 to 7. Patients were classified into three risk levels (low, moderate, high), correlating with observed rates of ICU admission and mortality. The system is built for low-complexity implementation in electronic health records (EHRs) or web-based triage dashboards and includes a software logic model with pseudocode. Results indicate that the score effectively distinguishes patient risk levels with statistical significance (p < 0.01), and can function as an early triage mechanism. The proposed model does not require laboratory data or imaging, making it particularly suitable for rapid deployment in both hospital and remote settings. This work demonstrates a pragmatic, interpretable, and scalable approach to clinical decision support in pandemic contexts involving vulnerable populations such as cancer patients.

3 March 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
E(Elena-Victoria Manea (Carneluti)
Elena-Victoria Manea (Carneluti)
CDCarmen Duta
Carmen Duta
MȘMircea-Sebastian Șerbănescu
Mircea-Sebastian Șerbănescu
IGIlona Andreea Georgescu
Ilona Andreea Georgescu
SAStefan-Alexandru Artene
Stefan-Alexandru Artene
ADAnica Dricu
Anica Dricu
Introduction: This study aims to construct a predictive model that classifies the severity of coronavirus disease 2019 (COVID-19) in cancer patients by analyzing clinical, radiological, and demographic data. The goal is to assist healthcare providers in identifying high-risk patients and ensuring optimal resource allocation. Materials and methods: Data from 237 cancer patients diagnosed with COVID-19 was utilized to forecast disease severity based on various predictors. Key factors included cancer type and stage, intensive care unit admission, radiological assessments, ventilation status, obesity, and systemic inflammatory response syndrome (SIRS). The performance of multiple machine learning (ML) models, including Error-Correcting Output Codes (ECOC) frameworks built on Support Vector Machines (SVM), Decision Trees, K-Nearest Neighbors (KNN), Naive Bayes, Discriminant Analysis and an ensemble bagging method, was evaluated using 10-fold cross-validation. Model accuracy and receiver operating characteristic (ROC) curve scores served as the primary evaluation metrics. Results: KNN and ensemble bagging emerged as the most effective models, achieving accuracy rates of 100% and 98.3%, respectively, along with high area under the curve (AUC) values. These models excelled at identifying severe cases associated with intensive care unit (ICU) admission, ventilation, and metastatic cancer. Decision Trees demonstrated satisfactory performance with an accuracy of 82.55%, while SVM and Discriminant Analysis yielded moderate accuracy (64.26% and 65.11%). Naive Bayes underperformed, achieving only 40% accuracy, largely due to its assumption of feature independence. Conclusions: KNN and ensemble bagging models successfully predicted severe COVID-19 outcomes in cancer patients by capturing intricate relationships between factors such as ICU stays and ventilator support. Decision Trees also showed promise, but Naive Bayes was less reliable due to its simplified approach. The findings underscore the importance of non-linear models for predicting complex clinical outcomes. Despite robust evaluation through 10-fold cross-validation, the possibility of overfitting—particularly with KNN’s flawless accuracy—remains a concern. Additionally, the absence of external validation constrains the broader applicability of these findings to different patient populations.